7月10日中银创新医疗混合A净值下跌0.61%，近1个月累计下跌2.55%

Group 1 - The core viewpoint of the news is the performance and holdings of the Zhongyin Innovation Medical Mixed A fund, which has shown a decline in recent net value but strong performance over the past six months and year-to-date [1] - As of July 10, 2025, the latest net value of Zhongyin Innovation Medical Mixed A is 1.9240 yuan, reflecting a decrease of 0.61%. The fund's return over the past month is -2.55%, ranking 3762 out of 3974 in its category. However, its six-month return is 69.25%, ranking 25 out of 3870, and its year-to-date return is 59.89%, ranking 26 out of 3868 [1] - The top ten stock holdings of Zhongyin Innovation Medical Mixed A account for a total of 70.44%, with significant positions in companies such as Kelun-Botai (9.77%), Hengrui Medicine (9.39%), and Innovent Biologics (8.54%) [1] Group 2 - Zhongyin Innovation Medical Mixed A was established on November 13, 2019, and as of March 31, 2025, it has a total scale of 2.613 billion yuan. The fund manager is Zheng Ning [1] - Zheng Ning has a background in finance and has held various positions in asset management, including roles at Taikang Asset Management and Zhonggeng Fund Management. He joined Zhongyin Fund Management in 2022 and has been managing multiple funds since then [2]